Show simple item record

dc.contributor.authorSharma-Chawla, Niharika
dc.contributor.authorStegemann-Koniszewski, Sabine
dc.contributor.authorChristen, Henrike
dc.contributor.authorBoehme, Julia D.
dc.contributor.authorKershaw, Olivia
dc.contributor.authorSchreiber, Jens
dc.contributor.authorGuzmán, Carlos A.
dc.contributor.authorBruder, Dunja
dc.contributor.authorHernandez-Vargas, Esteban A.
dc.date.accessioned2019-09-13T10:09:34Z
dc.date.available2019-09-13T10:09:34Z
dc.date.issued2019-08-14
dc.identifier.citationFront Immunol. 2019 Aug 14;10:1864. doi: 10.3389/fimmu.2019.01864. eCollection 2019.en_US
dc.identifier.issn1664-3224
dc.identifier.pmid31474978
dc.identifier.doi10.3389/fimmu.2019.01864
dc.identifier.urihttp://hdl.handle.net/10033/621935
dc.description.abstractAn overt pro-inflammatory immune response is a key factor contributing to lethal pneumococcal infection in an influenza pre-infected host and represents a potential target for therapeutic intervention. However, there is a paucity of knowledge about the level of contribution of individual cytokines. Based on the predictions of our previous mathematical modeling approach, the potential benefit of IFN-γ- and/or IL-6-specific antibody-mediated cytokine neutralization was explored in C57BL/6 mice infected with the influenza A/PR/8/34 strain, which were subsequently infected with the Streptococcus pneumoniae strain TIGR4 on day 7 post influenza. While single IL-6 neutralization had no effect on respiratory bacterial clearance, single IFN-γ neutralization enhanced local bacterial clearance in the lungs. Concomitant neutralization of IFN-γ and IL-6 significantly reduced the degree of pneumonia as well as bacteremia compared to the control group, indicating a positive effect for the host during secondary bacterial infection. The results of our model-driven experimental study reveal that the predicted therapeutic value of IFN-γ and IL-6 neutralization in secondary pneumococcal infection following influenza infection is tightly dependent on the experimental protocol while at the same time paving the way toward the development of effective immune therapies.en_US
dc.language.isoenen_US
dc.publisherFrontiers Media SAen_US
dc.rightsAttribution-NonCommercial-ShareAlike 4.0 International*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-sa/4.0/*
dc.titleIn vivo Neutralization of Pro-inflammatory Cytokines During Secondary Streptococcus pneumoniae Infection Post Influenza A Virus Infectionen_US
dc.typeArticleen_US
dc.contributor.departmentHZI,Helmholtz-Zentrum für Infektionsforschung GmbH, Inhoffenstr. 7,38124 Braunschweig, Germany.en_US
dc.identifier.journalFrontiers in Immunologyen_US
dc.source.volume10
refterms.dateFOA2019-09-13T10:09:35Z


Files in this item

Thumbnail
Name:
Sharma-Chawla et al.pdf
Size:
1.846Mb
Format:
PDF
Description:
Open Access publication

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-ShareAlike 4.0 International
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-ShareAlike 4.0 International